ellanse

Ellansé™ is a Unique and Innovative dermal filler which introduces a new era of safe and innovative solutions for facial beauty treatments.

The Ellansé Range combines the benefits of both immediate correction of wrinkles and folds as well as stimulating the generation of the body’s own natural collagen for beautiful, fresh and longer-lasting results.

Collagen is one of the important support structures found naturally in our skin, helping to maintain the appropriate tightness, elasticity and suppleness. Over the course of time, our skin gradually loses its natural collagen, leading to facial laxity and the formation of wrinkles and folds. ELLANSÉ™ uses the body’s natural response to stimulate the generation of the body’s own collagen (neocollagenesis) – restoring a fresh, youthful look.

ELLANSÉ addresses your needs for beautiful, fresh, longer-lasting and cost-effective results. Its four distinctive versions allow you to choose how long you would like the results to last, eliminating the need for frequent repeat treatments.

The ELLANSÉ Range is available in three versions, ELLANSÉ-S (1 year), ELLANSÉ-M (2 years) and ELLANSÉ-L (3 years).

Now also available for hand rejuvenation: ELLANSÉ HANDS-S and ELLANSÉ HANDS-M. Because a youthful face, deserves youthful hands.

Is Ellansé® Safe?

ELLANSÉ® is a Medical Device Class III8. It is CE approved (approved health and safety profile for use across the EU) since 2009. Ellansé has been used in the UK since 2010 and is distributed worldwid. It has high clinical safety data.

Reported Side Effects with Ellanse

Common, expected side efects, are the same as other dermal fillers and are injection related side effects like swelling, redness, and bruising. These side effects generally last maximum 1-2 days and are mild in nature.

What is Ellanse made from:

Ellansé is composed of PolyCaproLactone (PCL) microspheres suspended in a carrier gel. The carrier gel consists of Carboxymethyl Cellulose (CMC) made from non-animal, human or bacterial sources.

PCL is a well-known totally bioresorbable soft medical material, used in numerous European (CE-marked) and US Food and Drug Administration (FDA) approved commercial bioresorbable medical device applications like e.g. biodegradable sutures and orthopedic implants for several decades world-wide and has demonstrated an excellent safety profile.

CMC has been used in numerous European (CE-marked) and US Food and Drug Administration (FDA) approved commercial product applications in medical, cosmetic and pharmaceutical industries e.g. dermal fillers, oral and maxillo-facial surgery for several decades worldwide and has demonstrated an excellent safety profile.

Ellansé™ is developed, manufactured and marketed by AQTIS Medical BV. AQTIS Medical BV is a privately-held company based in Utrecht, the Netherlands.